Eli Lilly Corp. buy Deutsche Bank Aktiengesellschaft
Start price
03.10.24
/
50%
€802.20
Target price
03.10.25
€928.75
Performance (%)
-10.25%
End price
04.10.25
€720.00
Summary
This prediction ended on 04.10.25 with a price of €720.00. The price of Eli Lilly Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.25%. Deutsche_Bank_Aktien has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. A total of €2.66 was paid as dividends for this prediction. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -0.712% | -0.712% | 7.876% |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft. They now have a $1,025.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten